These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24557052)

  • 1. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.
    Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
    Eur Radiol; 2014 May; 24(5):1068-80. PubMed ID: 24557052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma.
    Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
    Eur Radiol; 2015 Jan; 25(1):24-31. PubMed ID: 25117747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters.
    Karlo CA; Donati OF; Burger IA; Zheng J; Moskowitz CS; Hricak H; Akin O
    Eur Radiol; 2013 Jun; 23(6):1738-44. PubMed ID: 23300041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
    Galmiche C; Bernhard JC; Yacoub M; Ravaud A; Grenier N; Cornelis F
    AJR Am J Roentgenol; 2017 Feb; 208(2):343-350. PubMed ID: 27959744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
    Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
    Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
    Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
    AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
    Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
    Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?
    Hindman N; Ngo L; Genega EM; Melamed J; Wei J; Braza JM; Rofsky NM; Pedrosa I
    Radiology; 2012 Nov; 265(2):468-77. PubMed ID: 23012463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
    Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
    Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors.
    Choi HJ; Kim JK; Ahn H; Kim CS; Kim MH; Cho KS
    Acta Radiol; 2011 Apr; 52(3):349-53. PubMed ID: 21498374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
    Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
    Kang HS; Park JJ
    Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas.
    Kuroda N; Toi M; Yamamoto M; Miyazaki E; Hayashi Y; Hiroi M; Shuin T; Enzan H
    Histol Histopathol; 2004 Jan; 19(1):23-8. PubMed ID: 14702167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA; Kim CK; Park SY; Cho SW; Park BK
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.